4th Immunotherapy of Cancer Conference

The Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer (SITC) have the great pleasure to invite you to take part in the 4th Immunotherapy of Cancer Conference (ITOC4) – the leading international conference providing a global platform in Europe for translational research in the field of immuno-oncology.

The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy.

The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017.
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.

IMPORTANT DATES:
Registration opens     September 1, 2016
Abstract submission opens     October 3, 2016
Abstract submission closes     November 30, 2016
Early rate registration closes     December 15, 2016
Regular rate registration closes     March 10, 2017
ITOC4 Congress     March 20 – 22, 2017

Others Details

For more details and updates please visit conference website